HOME >> BIOLOGY >> NEWS
PET accurately identifies esophageal cancer patients' positive responses to chemotherapy

WASHINGTON, D.C.Early metabolic imaging with positron emission tomography (PET) accurately identifies patients responding to chemotherapy for esophageal cancer, noted German researchers at the 54th Annual Meeting of SNM, the world's largest society for molecular imaging and nuclear medicine professionals.

"This is the first study to apply PET results from early metabolic response assessment to clinical decision making in the treatment of common solid tumors," said Ken Herrmann, a resident in the department of nuclear medicine at Technical University in Munich, Germany. "The outcome for metabolic responders turned out to be remarkably favorable compared to metabolic non-responders. Our results show that PET helps select patients who are benefiting from chemotherapy," he noted. "Based on our early response assessment, the course is set for tailoring multimodality treatment on the basis of tumor biology," explained Herrmann.

In addition, PET-response-guided treatment "helped circumvent the administration of inefficient chemotherapy to patients with no metabolic responsewithout compromising their outcome," added Herrmann.

Less well-known than lung cancerbut no less seriousesophageal cancer starts in the inner layer of the esophagus, the 10-inch long tube that connects your throat and stomach. Adenocarcinoma is esophageal cancer that begins in cells that make and release mucus and other fluids. In this country, more than 14,000 persons are expected to die from the disease, and more than 15,000 new cases will be diagnosed this year.

The MUNICON trial, conducted from May 2003 through August 2005, was the first study conducted to apply PET results from early metabolic response assessment to clinical decision-making in the treatment of common solid tumors, said Herrmann. "This clinical trial delineated how response-guided treatment algorithms may be applied to clinical practice, serving as a model for other malignant diseaseslike l
'"/>

Contact: Maryann Verrillo
mverrillo@snm.org
703-652-6773
Society of Nuclear Medicine
3-Jun-2007


Page: 1 2

Related biology news :

1. Fusing imaging technologies creates synergy, helps diagnose heart disease accurately
2. Preterm birth risk quickly and accurately detected with proteomic profiling
3. New research identifies anti-viral protein that may predict who might be at risk to develop lupus
4. U-M team identifies gene that regulates blood-forming fetal stem cells
5. Study identifies new gene therapy tools for inherited blindness
6. Study identifies energy efficiency as reason for evolution of upright walking
7. Study identifies a common genetic risk factor for colorectal and prostate cancer
8. M. D. Anderson team identifies new oncogene for brain cancer
9. Weill Cornell team identifies potential new cancer drug target
10. Study identifies 5 genetic themes key to keeping stem cells in a primitive, flexible state
11. 454 sequencing identifies HIV drug resistance at early stage

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/29/2019)... ... August 29, 2019 , ... Advancements ... robotics platform in an upcoming episode, which is scheduled to broadcast 1Q/2020. Check ... and commercialization of cost-effective robotic surgical solutions for the treatment of patients suffering ...
(Date:8/27/2019)... (PRWEB) , ... August 26, 2019 , ... Shoreline ... to the strain level, has hired Bill McKenzie as its CEO and Karen Woodward ... to help Shoreline Biome meet growing demand for its products and expand the company’s ...
(Date:8/27/2019)... , ... August 27, 2019 , ... ... science and drug development. This episode is scheduled to broadcast 4Q/2019. Check local ... a biopharmaceutical research, development, investment and manufacturing company. The show will highlight how ...
Breaking Biology News(10 mins):
(Date:8/27/2019)... (PRWEB) , ... August 27, 2019 , ... Dr. Kim ... She recently opened North Peninsula Veterinary Surgical Group , a new surgical practice ... there are plans to expand and add more veterinary specialists as the practice grows. ...
(Date:8/23/2019)... ... August 22, 2019 , ... The EnozoPro® converts ordinary tap water into ... and pathogens on hard surfaces including E. Coli, Salmonella, MRSA, Listeria and Legionella. It ... more information, visit the product page at rovingblue.com , ”At Enozo, our mission is ...
(Date:8/14/2019)... COLLEGE, Pa. (PRWEB) , ... August 13, 2019 ... ... in nuclear receptor and in vitro toxicology testing solutions, announced the appointment of ... healthcare industry experience to the Board. , Mark McLoughlin will lend his healthcare ...
(Date:8/7/2019)... SOLON, Ohio (PRWEB) , ... August 07, 2019 , ... ... with a breakthrough line of soil amendments (soil “probiotics”), including Rhizolizer ® , ... within a year—the largest impact any approach has offered to date. Results from the ...
Breaking Biology Technology:
Cached News: